Sun Pharmaceutical Industries Limited (Sun Pharma) and Taro Pharmaceutical Industries Ltd. (Taro) announced that they have entered into a definitive merger agreement in which Sun Pharma, Taro’s controlling shareholder, has agreed to acquire all of the outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates for US$43.00 per share in cash…
Sun Pharmaceutical Industries Limited, a specialty generic pharmaceutical company, announced the retirement of Kalyanasundaram Subramanian as Whole-time Director of the company, with effect from February 13, 2023. According to the company’s exchange filing, “The term of Mr. Kalyanasundaram Subramanian (DIN: 00179072), Whole-time Director would end on February 13, 2023, and accordingly he shall retire from…
Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or its associated companies, Sun Pharma) and Concert Pharmaceuticals, Inc. (Concert) announced that they have entered into a definitive agreement pursuant to which Sun Pharma will acquire all of the outstanding shares of Concert by way of a tender offer for an initial cash payment of 8.00…
Sun Pharmaceutical Industries Limited (Sun Pharma), announced that one of its subsidiaries, S.C. Terapia S.A., Romania has acquired the Uractiv portfolio from Fiterman Pharma in Romania. The Uractiv portfolio comprises food supplements including minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health. Uractiv is the No. 1 brand in its…